Chaoju Eye Care Holdings Limited submitted a Next Day Disclosure Return on 13 July 2026 confirming that its issued share capital remains unchanged at 705.18 million ordinary shares, with no treasury shares outstanding.

Key developments are as follows:

1. Latest on-market repurchase • Date: 13 July 2026 • Volume: 180,000 shares (0.026 % of issued shares) • Price range: HK$2.55–HK$2.59 per share • Consideration: HK$0.46 million These shares are earmarked for cancellation.

2. Cumulative repurchases pending cancellation (2 April–13 July 2026) • Total shares: 2.12 million, equal to roughly 0.30 % of current issued share capital. • Price range across the period: HK$2.43–HK$3.02 per share. • Estimated aggregate spend: about HK$5.56 million.

3. Repurchase mandate utilisation • Shareholders granted a mandate on 12 May 2026 allowing buy-backs of up to 70.52 million shares. • Shares repurchased under this mandate to date: 1.73 million, representing 0.25 % of the share base at mandate approval. • A 30-day moratorium on new share issues or treasury-share sales runs until 12 August 2026, in line with Hong Kong listing rules.

The company affirms that all repurchases were duly authorised by the board and executed in full compliance with Hong Kong Stock Exchange regulations and other applicable laws. Cancellation of the repurchased shares will follow standard settlement procedures; until completion, total issued shares remain at 705.18 million.